Area of research
Nephrology · Rheumatology
Research interest
Research interests include Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Systemic Lupus Erythematosus Research, and Vasculitis and related conditions.
Exome analysis links kidney malformations to developmental disorders and reveals causal genes
A meta-analysis of albuminuria as a surrogate endpoint for kidney failure
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy
A meta-analysis of GFR slope as a surrogate endpoint for kidney failure
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD
Evaluation of Variation in the Performance of GFR Slope as a Surrogate End Point for Kidney Failure in Clinical Trials that Differ by Severity of CKD
Randomized Phase II JANUS Study of Atacicept in Patients With IgA Nephropathy and Persistent Proteinuria
Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis
Clinical Outcomes of Patients with C3G or IC-MPGN Treated with the Factor D Inhibitor Danicopan: Final Results from Two Phase 2 Studies
Effects of Bardoxolone Methyl in Alport Syndrome
Baseline Clinical Characteristics and Complement Biomarkers of Patients with C3 Glomerulopathy Enrolled in Two Phase 2 Studies Investigating the Factor D Inhibitor Danicopan
Association of Treatment Effects on Early Change in Urine Protein and Treatment Effects on GFR Slope in IgA Nephropathy: An Individual Participant Meta-analysis
Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation
The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis
Longitudinal Changes in Health-Related Quality of Life in Primary Glomerular Disease: Results From the CureGN Study
Clinical trial recommendations for potential Alport syndrome therapies
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials
Health-related quality of life in glomerular disease
Contributions of Rare Gene Variants to Familial and Sporadic FSGS
The longitudinal relationship between patient-reported outcomes and clinical characteristics among patients with focal segmental glomerulosclerosis in the Nephrotic Syndrome Study Network
Whole-Exome Sequencing in Adults With Chronic Kidney Disease
An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome
CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
Clinical Characteristics and Treatment Patterns of Children and Adults With IgA Nephropathy or IgA Vasculitis: Findings From the CureGN Study